Atamyo Therapeutics, a biotechnology company focused on the development of new-generation gene therapies targeting neuromuscular diseases, announced multiple major milestones for ATA-100 and ATA-200,...
Axion BioSystems, a leading life science tools company focused on advanced live-cell assay platforms, announces that Kevin Gould has been appointed the company’s Chief...